2019年9月1日星期日

This Company Could Help Protect the Nation (and Your Portfolio)

You are receiving this as part of your free subscription to Tim Melvin's Max Wealth. To remove your email from this list, unsubscribe here.

Max Wealth

You Have 24 Hours to See This (Before it's Permanently Out of Reach)

This may be a best-case scenario for cannabis investors. Tom Gentile is showing you exactly how you can use this new cannabis-investing method for a shot at 10 times BIGGER profits - ones that hit way up to quadruple digits. Your chance at life-changing gains begins here - but it ends in just 24 hours. That's because once the clock strikes midnight on Monday, September 2, we're raising the price of access... permanently. Go here to take advantage of this opportunity - while you still can..


September 1, 2019

Dear Max Wealth Member,

Tensions are rising in Southeast Asia.

The U.S.-Chinese trade dispute has put more pressure on Beijing to expand their economic horizons.

China has been aggressively pushing into the South China Sea for years, going so far as to build island military installations and extend their reach beyond their borders, moving ever closer to territory claimed by their neighbors like the Philippines, Vietnam, and Taiwan.

There's a massive economic incentive for China to control this region for themselves, too. Experts estimate there could be as much as 130 billion barrels of oil, and 900 trillion cubic feet of natural gas sitting under the water.

If something were to happen that the Chinese tried to take their bullying up a level or two, then the U.S. would likely have to step in to help. Not surprising, the Chinese military isn't very happy about our presence in the region.

If their military were to try, they would probably use the DF-21D "carrier killer" missile. The Chinese government believes this weapon could tip the balance of power in the region to their favor.

These missiles have a range so large and a top speed so fast that, you could launch one of these missiles in Manhattan and hit a target in Miami in just over 10 minutes.

But America has a new superweapon - the Mach 7 Cannon - that uses electricity to fire computer-guided projectiles at ridiculous supersonic speeds in the blink of an eye.

This superweapon can unleash so many bullets so quickly and accurate that they'll make the "Assassin's Mace" as effective as a pop gun.

This is the very definition of a battlefield game-changer.

It's thanks to the efforts of this small U.S. defense contractor and the thousands of Americans it employs. They've invented the new arsenal of democracy.

As this new technology comes to market, even a small stake from early investors could be rewarded with massive returns.

Right here in this detailed report, you can learn more about this company and how you can take advantage of this unique opportunity.



Markets have certainly not become any less confusing over the past week. Trade discussions continue to bounce around and the political noise seems to hit new highs every time you turn around. The consensus opinion appears to be that interest rates will never rise again, and it is not just lower for longer. Now it is lower for pretty much forever.

The numbers continue to tell a story of larger, more closely-followed companies being overvalued and the bargains being in the darker corners of the markets right now. This week's recommendation fits somewhere between special situations and private equity buyout candidate.

Private equity has been hot on this company's trail as it's approaching one of its industry's biggest revenue generating seasons. Meanwhile, an emerging technology has pushed the company into revenue streams that have grown by over 25% per year for nearly a decade.

With this special season quickly approaching, it's an excellent time to take advantage of this opportunity. Click here and find out why you should add this Heatseeker to your portfolio.

To the Max,


Tim Melvin


Secret Government Program Could Save over 2 Million People's Lives with "Miracle Biotech"

Deep in Afghanistan, the military conducted a secret operation to test a radical new technology. The operation was a success, and now over two million people per year could be saved by this amazing technology. And one tiny biotech firm holds all the rights in the U.S. See all the details here.


You are receiving this e-mail at its028@gmail.com, as a part of your free subscription to Tim Melvin's Max Wealth.

To remove your email from this list: Unsubscribe

Manage Your Email Preferences

To cancel by mail or for any other subscription issues, write us at:
Tim Melvin's Max Wealth | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201
North America: 888.384.8339; International: 443.353.4519; Fax: 410.622.3050
Contact Customer Service
Website: https://maxwealth.com/

© 2019 Tim Melvin's Max Wealth All Rights Reserved.
Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.

We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Tim Melvin's Max Wealth. 1125 N Charles Street, Baltimore MD 21201.

没有评论:

发表评论